AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000061 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
20,262
Total Value
$113,224.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common stock | โ | Apr 2, 2026 | Exercise/Conversion | 8,500 | $0.00 | $0.00 | 50,091 | Direct | โ | View Details | |
Chief Commercial Officer | Common stock | โ | Apr 2, 2026 | Sale | 3,262 | $34.71 | $113,224.02 | 46,829 | Direct | โ | View Details | |
Chief Commercial Officer | Performance share units | Derivative | Apr 2, 2026 | Exercise/Conversion | 8,500 | $0.00 | $0.00 | 8,500 | Direct | โ | View Details |